Siegfried Holding AG (SWX:SFZN)

Market Cap	3.15B
Revenue (ttm)	1.29B
Net Income (ttm)	154.10M
Shares Out	43.77M
EPS (ttm)	3.51
PE Ratio	20.49
Forward PE	18.09
Dividend	0.38 (0.53%)
Ex-Dividend Date	Apr 22, 2025

Volume	87,052
Average Volume	85,203
Open	72.40
Previous Close	72.20
Day's Range	71.50 - 72.70
52-Week Range	53.70 - 112.20
Beta	0.70
RSI	38.16
Earnings Date	Feb 20, 2026

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1873
• Employees: 3,886
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SFZN

Financial Performance

In 2024, Siegfried Holding AG's revenue was 1.29 billion, an increase of 1.82% compared to the previous year's 1.27 billion. Earnings were 160.06 million, an increase of 41.93%.